Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers

Journal of Clinical Oncology

Volumn 30, Issue 2, 2012, Pages 142-150

  Wu, Xiao Cheng ^a   Lund, Mary Jo ^b   Kimmick, Gretchen G ^d   Richardson, Lisa C ^c   Sabatino, Susan A ^c   Chen, Vivien W ^a   Fleming, Steven T ^e   Morris, Cyllene R ^g   Huang, Bin ^f   Trentham Dietz, Amy ^h   Lipscomb, Joseph ^b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b EMORY UNIVERSITY   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF KENTUCKY   (United States)

^g PUBLIC HEALTH INSTITUTE   (United States)

^h UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; PACLITAXEL; PROGESTERONE RECEPTOR; TAMOXIFEN;

ADULT; AFRICAN AMERICAN; AGE; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER INVASION; COMORBIDITY; DISEASE SEVERITY; EUROPEAN AMERICAN; FEMALE; HEALTH EDUCATION; HEALTH INSURANCE; HISPANIC; HOSPITAL; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAID; MEDICARE; POVERTY; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; RACE; SOCIAL STATUS; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; GUIDELINE ADHERENCE; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HOSPITALS; HUMANS; INSURANCE, HEALTH; MIDDLE AGED; SOCIAL CLASS; UNITED STATES; YOUNG ADULT;

EID: 84862907799     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.36.8399     Document Type: Article

References (37)

1. Mariotto AB, Feuer EJ, Harlan LC, et al: Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999. J Natl Cancer Inst Monogr 36:7-15, 2006
2. Early Breast Cancer Trialists' Collaborative Group (EBCTCG): Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 365:1687-1717, 2005
3. Adjuvant therapy for breast cancer. NIH Consensus Statement Online - November 1-3, 2000. 17:1-23. http://consensus.nih.gov/2000/ 2000AdjuvantTherapyBreastCancer114html.htm
4. National Comprehensive Cancer Network: Clinical practice guidelines in oncology (version 1.2010). http://www. nccn.org/professionals/physician-gls/ recently-updated.asp
5. Eifel P, Axelson JA, Costa J, et al: National Institutes of Health Consensus Development Conference Statement: Adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst 93:979-989, 2001
6. Freedman RA, Virgo KS, He Y, et al: The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care. Cancer 117:180-189, 2011
7. Bhargava A, Du XL: Racial and socioeconomic disparities in adjuvant chemotherapy for older women with lymph node-positive, operable breast cancer. Cancer 115:2999-3008, 2009
8. Harlan LC, Greene AL, Clegg LX, et al: Insurance status and the use of guideline therapy in the treatment of selected cancers. J Clin Oncol 23:9079-9088, 2005
9. Malin JL, Diamant AL, Leake B, et al: Quality of care for breast cancer for uninsured women in california under the breast and cervical cancer prevention treatment act. J Clin Oncol 28:3479-3484, 2010
10. Edwards BK, Brown ML, Wingo PA, et al: Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97:1407-1427, 2005 (Pubitemid 41520077)
11. Bilimoria KY, Bentrem DJ, Stewart AK, et al: Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: Implications for studies that use the National Cancer Data Base. J Clin Oncol 27:4177-4181, 2009
12. Harlan LC, Klabunde CN, Ambs AH, et al: Comorbidities, therapy, and newly diagnosed conditions for women with early stage breast cancer. J Cancer Surviv 3:89-98, 2009
13. McDavid K, Schymura MJ, Armstrong L, et al: Rationale and design of the National Program of Cancer Registries' Breast, Colon, and Prostate Cancer Patterns of Care Study. Cancer Causes Control 15:1057-1066, 2004 (Pubitemid 41460296)
14. Griggs JJ, Culakova E, Sorbero ME, et al: Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens. J Clin Oncol 25:2522-2527, 2007 (Pubitemid 47041224)
15. Griggs JJ, Sorbero ME, Stark AT, et al: Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy. Breast Cancer Res Treat 81:21-31, 2003 (Pubitemid 37108437)
16. Bickell NA, Wang JJ, Oluwole S, et al: Missed opportunities: Racial disparities in adjuvant breast cancer treatment. J Clin Oncol 24:1357-1362, 2006 (Pubitemid 46621998)
17. Commission on Cancer of the American College of Surgeons and the American Cancer Society: National cancer data base. http://www.facs.org/cancer/ncdb/ index.html
18. Iyengar R, Lund MJ, Lamson P, et al: Using National Quality Forum breast cancer indicators to measure quality of care for patients in an AVON comprehensive breast center. Breast J 16:240-244, 2010
19. North American Association of Central Cancer Registries Latino Research Work Group: NAACCR guideline for enhancing Hispanic-Latino identification: Revised NAACCR Hispanic/Latino identification algorithm [NHIA V2], September 2005. http://www.naaccr.org/DataandPublications/EpiReports.aspx
20. Espey DK, Wu XC, Swan J, et al: Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer 110:2119-2152, 2007 (Pubitemid 350100734)
21. Krieger N, Chen JT, Waterman PD, et al: Race/ethnicity, gender, and monitoring socioeconomic gradients in health: A comparison of areabased socioeconomic measures - The public health disparities geocoding project. Am J Public Health 93:1655-1671, 2003 (Pubitemid 38477631)
22. Siminoff LA, Zhang A, Saunders Sturm CM, et al: Referral of breast cancer patients to medical oncologists after initial surgical management. Med Care 38:696-704, 2000
23. Piccirillo JF, Creech C, Zequeira R, et al: Inclusion of comorbidity into oncology data registries. J Registry Manag 26:66-70, 1999
24. SAS Institute: SAS/STAT 9.2 User's Guide: Survey Data Analysis (book excerpt). Cary, NC, SAS Institute, 2009, pp 25-194
25. DeMichele A, Putt M, Zhang Y, et al: Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma: Evidence from a tertiary care cohort of chemotherapy-eligible patients. Cancer 97:2150-2159, 2003 (Pubitemid 36444055)
26. Brunello A, Basso U, Pogliani C, et al: Adjuvant chemotherapy for elderly patients (> or = 70 years) with early high-risk breast cancer: A retrospective analysis of 260 patients. Ann Oncol 16: 1276-1282, 2005 (Pubitemid 41158471)
27. Lund MJ, Brawley OP, Ward KC, et al: Parity and disparity in first course treatment of invasive breast cancer. Breast Cancer Res Treat 109:545-557, 2008 (Pubitemid 351692062)
28. Worthington J, Waterbor JW, Funkhouser E, et al: Receipt of standard breast cancer treatment by African American and White women. Int J Med Sci 5:181-188, 2008 (Pubitemid 352000030)
29. Ayanian JZ, Kohler BA, Abe T, et al: The relation between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med 329:326-331, 1993 (Pubitemid 23210686)
30. Voti L, Richardson LC, Reis I, et al: The effect of race/ethnicity and insurance in the administration of standard therapy for local breast cancer in Florida. Breast Cancer Res Treat 95:89-95, 2006 (Pubitemid 43228085)
31. LaPar DJ, Bhamidipati CM, Mery CM, et al: Primary payer status affects mortality for major surgical operations. Ann Surg 252:544-550; discussion 550-551, 2010
32. Cheong PH, Feeley TH, Servoss T: Understanding health inequalities for uninsured Americans: A population-wide survey. J Health Commun 12:285-300, 2007 (Pubitemid 46752417)
33. Degner LF, Kristjanson LJ, Bowman D, et al: Information needs and decisional preferences in women with breast cancer. JAMA 277:1485-1492, 1997 (Pubitemid 27208893)
34. Peele PB, Siminoff LA, Xu Y, et al: Decreased use of adjuvant breast cancer therapy in a randomized controlled trial of a decision aid with individualized risk information. Med Decis Making 25:301-307, 2005 (Pubitemid 40696279)
35. Ashing-Giwa KT, Padilla G, Tejero J, et al: Understanding the breast cancer experience of women: A qualitative study of African American, Asian American, Latina and Caucasian cancer survivors. Psychooncology 13:408-428, 2004 (Pubitemid 38832606)
36. Hewitt M, Simone J: Ensuring Quality Cancer Care. Washington, DC, National Academies Press, 1999, pp 58-63
37. Yen TW, Czypinski LK, Sparapani RA, et al: Socioeconomic factors associated with adjuvant hormone therapy use in older breast cancer survivors. Cancer 117:398-405, 2011